Sonendo Inc
OTC:SONX
Sonendo Inc
Research & Development
Sonendo Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sonendo Inc
OTC:SONX
|
Research & Development
-$6.8m
|
CAGR 3-Years
28%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Research & Development
-$1.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$2.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-21%
|
|
Sonendo Inc
Glance View
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 219 full-time employees. The company went IPO on 2021-10-29. The firm has developed GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company is focused on leveraging the GentleWave System, a root canal therapy for late-stage tooth decay that employs a sterilized, single-use procedure instrument. In addition to its GentleWave console and single-use procedure instruments, it also offers single-use products, such as SoundSeal and the Company's Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown. Its EDTA is a liquid used during the GentleWave Procedure to help debride and disinfect the root canal system. The company also offers TDO practice management software.
See Also
What is Sonendo Inc's Research & Development?
Research & Development
-6.8m
USD
Based on the financial report for Dec 31, 2024, Sonendo Inc's Research & Development amounts to -6.8m USD.
What is Sonendo Inc's Research & Development growth rate?
Research & Development CAGR 5Y
19%
Over the last year, the Research & Development growth was 33%. The average annual Research & Development growth rates for Sonendo Inc have been 28% over the past three years , 19% over the past five years .
